TLDR Sublingual minoxidil safely promotes hair growth.
The document reports on a randomized, double-blind, placebo-controlled, phase 1B clinical trial of sublingual minoxidil for the treatment of male and female pattern hair loss. The study found that sublingual minoxidil was safe and effective in promoting hair growth, with a significant increase in hair count observed in the treatment group compared to the placebo group. The authors suggest that sublingual minoxidil may be a promising treatment option for individuals with hair loss. Further studies are needed to determine the optimal dose of sublingual minoxidil and compare its efficacy to oral minoxidil.
Cited in this study
7 / 7 results
16 citations
,
May 2020 in “Journal of The European Academy of Dermatology and Venereology” Sublingual minoxidil effectively treats hair loss with mild side effects.
4 citations
,
January 2020 in “Dermatologic Therapy” Hair enzyme activity predicts minoxidil success in Brazilian women with hair loss.
52 citations
,
August 2019 in “Journal of The American Academy of Dermatology” Low-dose oral minoxidil effectively improves male hair loss with mild side effects.
59 citations
,
February 1998 in “Chemico-Biological Interactions” Minoxidil breakdown varies by enzymes, affecting hair loss treatment effectiveness.
5 citations
,
February 1996 in “Clinical pharmacology and therapeutics/Clinical pharmacology & therapeutics” Minoxidil given intravenously caused small changes in diastolic blood pressure and increased heart rate at higher concentrations in patients with high blood pressure.
25 citations
,
February 1989 in “The Journal of Clinical Pharmacology” This document studied minoxidil in healthy volunteers. Minoxidil is quickly absorbed and eliminated from the body.
57 citations
,
January 1980 in “Journal of Cardiovascular Pharmacology” Minoxidil treats high blood pressure and side effects can be managed.